IJCRR - 8(21), November, 2016
CLINICAL STUDY OF CONTEMPORARY PATTERN AND OUTCOME OF HYPERTENSION IN PREGNANCY AMONG PRIMIPAROUS AND MULTIPAROUS WOMEN IN A TERTIARY CARE CENTRE
Author: Renukadevi B., Kavitha G., Rathna Ramamurthy, Raja rajeshwari
Introduction: Hypertension complicates 10% of all pregnancies. Various adverse outcomes of hypertension in pregnancy include antepartum hemorrhage, postpartum hemorrhage, acute renal and hepatic failure, maternal death, preterm birth, intrauterine growth retardation, and neonatal death. Despite various screening tools, there is high prevalence of hypertension in pregnancy and its related complications. Periodical analysis such cases are of utmost importance as it may help in early identification of the problem and measures to prevent its complications.
Objectives: The objectives of this study is to identify the difference in pattern of hypertension in primiparous and multiparous women and its maternal and fetal outcomes and differences in lab parametersin both groups.
Methodology: This was a retrospective study conducted among 88 women with hypertension and /or proteinuria complicating pregnancy who were admitted for delivery in the department of obstetrics and gynaecology, Velammal Medical College over a period of 1 year (Aug 2015 – July 2016). The data were collected from the patients’ records. The patients were divided into two groups, primiparous and multiparous. The data were collected in terms of age, parity, gestational age, mode of delivery, birth weight of baby and complications. The results were statistically analysed with IBM SPSS statistics software 23.0 version.
Results: The frequency of hypertensive disorders of pregnancy was 11.6 % in our study. The prevalance of eclampsia was 0.7%. The mean gestational age of babies was 39 weeks and 36 weeks in mild and severe preeclampsia in primiparous women and 37.5 and 34.2 weeks in multiparous women. The mean platelet count in mild and severe cases were 2.5 and 1.8 lakhs/cu mm in primiparous and 2.4 and 1.9 lakhs/cu mm in multiparous women.
Conclusion: Though the prevalence of hypertension in primiparous women is more, the prevalence of severe preeclampsia in more common in multiparous women. Almost all cases of eclampsia occurred in primiparous women. A different pathophysiology could be a cause of hypertension in pregnancy in primiparous and multiparous women, as implied by significant differences in both groups.
Keywords: Eclampsia, Gestational hypertension, Hypertension, IUGR, Preeclampsia
Renukadevi B., Kavitha G., Rathna Ramamurthy, Raja rajeshwari. CLINICAL STUDY OF CONTEMPORARY PATTERN AND OUTCOME OF HYPERTENSION IN PREGNANCY AMONG PRIMIPAROUS AND MULTIPAROUS WOMEN IN A TERTIARY CARE CENTRE International Journal of Current Research and Review. 8(21), November, 19-24
1. Al-Ghamdi Saeed MG, Al-Harbi AS, Khalil A, El-yahya AR. Hypertensive disorders of pregnancy: prevalence, classification and adverse outcomes in northwestern Saudi Arabia. Annals of Saudi Medicine Journal 1999; 19:557-560.
2. MoodleyJ.South Africa Med.j.CME-1991;9:72.
3. World Health Organization. Global Program to Conquer Preeclampsia/Eclampsia.2002.
4. Dolcea C. AbouZahr C. Global burden of hypertensive disorders of pregnancy in year 2002. In: Global Burden of Diseases;2000; World Health Organisation..
5. Zibaeenazhad MJ, M Ghodsi P Arab, Gholzom N. the prevalence of hypertensive disorders of pregnancy in Shiraz, Southern Iran; Iranian Cardiovascular Research Journal 2010; 4:169-172
6. J.Nadkarni, J. Bahl, P. Parekh. Perinatal outcome in pregnancy associated hypertension, Indian pediatrics 2001,38:174-178
7. Al-Mulhim AA, Abu-Heija A, AlJamma F, El-Harith el-HA. Preeclampsia: maternal risk factors and perinatal outcome. Fetal Diagn Ther. 2003; 18 (4): 275-80.
8. Miguil M, Chekairi A. Eclampsia, Study of 342 cases. Hypertension in Pregnancy. 2008; 27 (2): 103-11.
9. Dissanayake VH, Samarasinghe HD, Morgan L, Jayasekara RW, Seneviratne HR, Pipkin FB. Morbidity and mortality associated with preeclampsia at two tertiary care hospitals in Sri Lanka. J Obstet Gynaecol Res. 2007; 33 (1): 56-62.
10. Eskenazi B, Fenster L, Sidney S, Elkin EP. Fetal growth retardation in infants of multiparous and nulliparous women with preeclampsia. Am J Obstet Gynecol 1993; 169: II 12-8.
11. Gleicher N, Boler LR, Norusis M, Del Granado A Hypertensive diseases of pregnancy and parity. Am J Obstet Gynecol 1986; 154: I 044-9.
12. Gibson G, Hunter D, Neame PB, Kelton JG. Thrombocytopenia in pre-eclampsia and eclampsia. Semin Thromb Hemost. 1982;8:234-247.
13. Pritchard JA, Cunningham FG, Mason RA. Coagulation changes in eclampsia: their frequency and pathogenesis. Am J Obstet Gynecol. 1976;8:855-864.
14. Kang DH, Finch J, Nakagawa T, Karumanchi SA, Kanellsi J, Granger J, Johnson RJ. Uric acid, endothelial dysfunction and pre-eclampsia: searching for a pathogenetic link. Journal of hypertension. 2004; 22:229–235. [PubMed: 15076175]
15. Bainbridge SA, Roberts JM. Uric Acid as a Pathogenic Factor in Preeclampsia. Placenta. 2008 29S: 67–72.
16. Feig DI, Nakagawa T, Karumanchi SA, Oliver WJ, Kang DH, Finch J, Johnson RJ. Hypothesis: Uric acid, nephron number, and the pathogenesis of essential hypertension. Kidney international. 2004; 66:281–287. [PubMed: 15200435]
17. ACOG Committee on Obstetric Practice. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. No. 33, January 2002.
18.American College of Obstetricians and Gynecologists. Obstet Gynecol 2002;99:159-67Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000;183:S1-22.
19. Livingston JC, Livingston LW, Ramsey R, Mabie BC, Sibai BM. Magnesium sulfate in women with mild preeclampsia: a randomized controlled trial. Obstet Gynecol 2003;101:217-20.